Clinical Trial Update: Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation. [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing two new Premarin/medroxyprogesterone acetate formulations with the reference Premarin/MPA product; study completed in pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Premarin/MPA (conjugated estrogens; medroxyprogesterone acetate)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Postmenopausal Osteoporosis, Postmenopause | Phase 1 | Status: COMPLETED